Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Medtronic Tops Q2 Earnings, Lowers FY17 Guidance
Article By:
Zacks Investment Research
Tuesday, November 22, 2016 11:10 AM EDT
Medtronic plc reported financial results for second-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.12, a penny ahead of the Zacks Consensus Estimate and up 8.7% year over year.
Morning Call For Thursday, Nov. 10
Article By:
Jim Van Meerten
Thursday, November 10, 2016 9:03 AM EDT
Dec E-mini S&Ps (ESZ16 +0.32%) are up +0.58% at a 2-month high as drug makers and bank stocks rallied in pre-market trading on speculation the Trump administration will mean less regulatory oversight in those sectors than had Mrs. Clinton won.
Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance
Article By:
Zacks Investment Research
Wednesday, November 9, 2016 6:00 AM EDT
Shares of pharmaceutical company, Valeant Pharmaceuticals Inc. fell over 21% after the company reported disappointing third-quarter 2016 results and slashed its sales and earnings outlook for the year.
CVS Health Tops Q3 Earnings Estimates, Cuts '16 View
Article By:
Zacks Investment Research
Tuesday, November 8, 2016 1:15 PM EDT
CVS Health Corporation reported third-quarter 2016 adjusted earnings per share (EPS) of $1.64, up 28.1% year over year.